课题基金 / 基金详情

The Institute for Translational Medicine

The Institute for Translational Medicine
转化医学研究所
批准号:
10673867
负责人:
Joshua J Jacobs
金额:
$822.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-06 至 2027-06-30

项目摘要

项目成果

Joshua J Jacobs的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT ITM 3.0: ADVANCING HEALTH TOWARD HEALTH EQUITY THROUGHOUT METROPOLITAN CHICAGO The University of Chicago – Rush University Institute for Translational Medicine (ITM) was created in 2007 to assemble, integrate, and create the intellectual, administrative, and physical resources required to catalyze research and research training in Clinical and Translational Science. We have trained university scientists and health care providers as well as stakeholders from concerned communities to work together to determine the biological, behavioral, and social determinants of disease; to develop and test interventions directed toward those mechanisms; and to achieve these goals in a way that is rigorous, efficient, ethical, respectful of, and responsive to our communities’ priorities and values. The ITM has capitalized on outstanding intellectual and physical resources throughout UChicago, Rush, and ITM affiliate institutions – Loyola University Chicago, NorthShore University HealthSystem, Advocate Aurora Health Care, and Illinois Institute of Technology – and on substantial multi-institutional investments to build the sustainable infrastructure for a transformative, energetic, and self-improving home for clinical and translational research. Now, we pursue a bold guiding vision for “ITM 3.0” – that reversing the adverse health consequences of structural racism requires accounting for and mitigating the social, environmental, behavioral, and psychological factors (the entire lived experience, which we will call the “sociome”) through which structural racism impairs health. Focus on the sociome is critical because: 1) sociome factors interact with human biology to exacerbate or cause disease and injury, and 2) illness of any origin can compound the negative effects of adverse sociome factors. Since both sociome and biological systems, and their interactions, determine health, our CTSA hub must provide investigators, trainees, and stakeholders with the resources and knowledge to account for and address health disruptors throughout both systems. Our strategy to implement this vision is to create new training mechanisms, research platforms, communications channels, and safeguards against harm to ensure that all ITM investigators and institutions approach health problems with a wider-angle sociome lens in an ethical way. Then, our scientific, institutional, and community stakeholders can together design, test, and disseminate biological and/or sociome-directed interventions at the levels of individual, community, and society to improve mutually defined health concerns. ITM 3.0 will work hand-in-hand with partners throughout Chicagoland and the nation, combining academic rigor with community wisdom to conceptualize, develop and deploy innovative, just, and ethical interventions/practices to achieve our common goal, and so lessen the health impact of structural racism.
期刊论文(107)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1177/0885066620973917
发表时间: 2022-01
期刊: Journal of intensive care medicine
影响因子: 3.1
作者: [Ward MA, Kuttab HI, Lykins V JD, Wroblewski K, Hughes MD, Keast EP, Kopec JA, Rourke EM, Purakal J]
通讯作者: Purakal J
DOI: 10.1371/journal.pone.0244285
发表时间: 2021
期刊: PloS one
影响因子: 3.7
作者: [Barlass U, Deshmukh A, Beck T, Bishehsari F]
通讯作者: Bishehsari F
DOI: 10.3390/jpm12071145
发表时间: 2022-07-15
期刊: JOURNAL OF PERSONALIZED MEDICINE
影响因子: --
作者: [Saulsberry, Loren, Singh, Lavisha, Pruitt, Jaclyn, Ward, Christopher, Wake, Dyson T., Gibbons, Robert D., Meltzer, David O., O'Donnell, Peter H., Cruz-Knight, Wanda, Hulick, Peter J., Dunnenberger, Henry M., David, Sean P.]
通讯作者: David, Sean P.
DOI: 10.1016/j.clinimag.2021.11.013
发表时间: 2022-03
期刊: Clinical imaging
影响因子: 2.1
作者: [Chauhan D, Anyanwu E, Goes J, Besser SA, Anand S, Madduri R, Getty N, Kelle S, Kawaji K, Mor-Avi V, Patel AR]
通讯作者: Patel AR
65
    The Institute for Translational Medicine
    • 批准号:
      10632295
    • 项目类别:
    • 资助金额:
      $829.87万
    • 财政年份:
      2017
    • 负责人:
      Joshua J Jacobs
    • 依托单位:
    ITM 2.0: Advancing Translational Science in Metropolitan Chicago
    • 批准号:
      10206314
    • 项目类别:
    • 资助金额:
      $604.85万
    • 财政年份:
      2017
    • 负责人:
      Joshua J Jacobs
    • 依托单位:
    ITM 2.0: Advancing Translational Science in Metropolitan Chicago
    • 批准号:
      9928708
    • 项目类别:
    • 资助金额:
      $68.54万
    • 财政年份:
      2017
    • 负责人:
      Joshua J Jacobs
    • 依托单位:
    ITM 2.0: Advancing Translational Science in Metropolitan Chicago
    • 批准号:
      10217598
    • 项目类别:
    • 资助金额:
      $22.82万
    • 财政年份:
      2017
    • 负责人:
      Joshua J Jacobs
    • 依托单位:
    海外基金